Date closed: 6/22/2016
Value: US$7 million
On June 22, 2016, Aurinia Pharmaceuticals Inc. closed a US$7,080,000 private placement. Under the terms of the Offering, the Company issued 3,000,000 units at a subscription price per Unit of US$2.36, each Unit consisting of one common share and US$0.35 of one common share purchase warrant.
BLG represented Aurinia Pharmaceuticals Inc. by Stephen P. Robertson and Michelle M. Wilkinson.